Natasha K. Martin , DPhil, is an Associate Professor in the Division of Global Public Health in the Department of Medicine at the University of California San Diego. She is also an Honorary Senior Lecturer at the University of Bristol. Dr. Martin is an infectious disease and economic modeler. Dr. Martin’s work focuses on using dynamic epidemic modeling to evaluate the impact and cost-effectiveness of HIV, HCV, and HBV prevention interventions among high risk populations such as people who inject drugs, men who have sex with men, and incarcerated populations. She is one of the leading researchers examining the potential impact and cost-effectiveness of HCV treatment as prevention.

Dr. Jorge Mera is the director of infectious diseases for Cherokee Nation Health Services (CNHS), the largest tribally operated health care system in the United States. During the last years his efforts have been dedicated to organizing the Cherokee Nation HCV elimination program as well as the HIV/HCV Extended Care Health Outcomes (ECHO) project in the tribe. He is also the Director of the HIV clinic since 2012 and the Director of the only Native American AETC local performance site in Oklahoma since 2013. Dr. Mera completed his fellowship in Infectious Diseases and Clinical Microbiology at Baylor College of Medicine in Houston, Texas and is Board Certified by the American Board of Internal Medicine (ABIM) in Infectious Diseases. He is a Clinical Assistant Professor in the Department of Internal Medicine of the Oklahoma State University Health Science Center and a Fellow of the American College of Physicians.

Infectious Disease doctor with more than 20 years in the field of viral hepatitis as a doctor and researcher, activist and stakeholder. Member of the Viral Hepatitis Scientific Advisory Board of Brazil MOH and WHO. Researcher on viral hepatitis at University of Sao Paulo. Former coordinator (and creator) of the Viral Hepatitis Program at the city of Sao Paulo. Senior advisor in charge of the implementation of interferon free therapy in Brazil by the MOH (2014-2015).

Dr. John Ward is Director of the Division of Viral Hepatitis at the CDC. During his tenure, Dr. Ward has guided development of national viral hepatitis surveillance, prevention research, policies and programs including those to promote education, vaccination, and testing with linkage to care and treatment. Dr. Ward initiated two Institute of Medicine (IOM) reviews of viral hepatitis prevention in the United States, and authored the first Action Plan for Viral Hepatitis Prevention, Care, and Treatment for the United States. Globally, Dr. Ward serves as an expert consultant to the World Health Organization, other international organizations and national ministries of health. Dr. Ward’s experience includes 14 years in the field of HIV/AIDS conducting early studies of HIV transmission, natural history and directing national HIV/AIDS surveillance. Dr. Ward has authored over 150 scientific publications, served as Editor of CDC’s Morbidity and Mortality Weekly Report (MMWR), and served as Editor for Silent Victories, a history of public health in the 20th century published in 2007 by Oxford University Press. Dr. Ward received his MD degree from the University of Alabama School of Medicine in Birmingham and completed an internship and residency in internal medicine at the University of Alabama Hospitals. He holds a clinical faculty appointment with the Department of Medicine, Emory University, Atlanta, GA.